NEW YORK, Jan 13 (Reuters) – The U.S. Supreme Court on
Friday agreed to hear a dispute over whether companies that make
copycat versions of biologic drugs must wait six months after
winning federal…
The post U.S. Supreme Court agrees to hear dispute over biologic drug sales appeared first on NASDAQ.